⭐ Featured Analysis
AAN and AHS Release Updated Adult Migraine Prevention Pharmacotherapy Guideline
New guidelines optimize migraine prevention with personalized strategies.
Read Full Analysis →Newest Analyses
Cardiology / AnticoagulationAsundexian Cuts Recurrent Stroke Without Excess Bleeding
Cardiology / AnticoagulationFactor XIa Inhibitors: Indication-Specific Anticoagulation, Not Broad DOAC Replacement
Cardiology / AnticoagulationOCEANIC-AF: Asundexian Fails Stroke Prevention Versus Apixaban
Cardiology / AnticoagulationFactor XI Inhibitors Cut Bleeding but Raise Ischemic Stroke in AF
💊 Clinical Pearl of the Week
Tirzepatide Resolves MASH but Fibrosis Benefit Remains Unproven Gastroenterology / Hepatology
ALT normalization occurred in up to 75% of the 15-mg group but is a biomarker signal, not histologic proof of fibrosis regression, so avoid overinterpreting transaminase trends.
⚡ Practice-changing
- AAN and AHS Release Updated Adult Migraine Prevention Pharmacotherapy Guideline
- IDSA Multisociety Position Paper: Hospital Strategies to Improve Sepsis Outcomes
- Fresenius Kabi Recalls One Lot of Tyenne (tocilizumab-aazg) for Glass Particles
- Network Meta-Analysis Ranks 21 Antidepressants for Acute Depression
Most-read this week
1Co-designing a pharmacist-led emergency department transition-of-care blueprintGeriatrics / Geriatric Pharmacy
2ECIL-10 Reshapes Febrile Neutropenia Antibiotic Strategy Around StewardshipInfectious Disease / Antimicrobials
3AAN and AHS Release Updated Adult Migraine Prevention Pharmacotherapy GuidelineNeurology / Neuropharmacology